Trial intelligence / Profile preview

TOBY Xe: Xenon gas combined with therapeutic hypothermia after perinatal asphyxia

2009-014344-11Phase 2Completed

Sponsor
Imperial College London
Start
Mar 2010
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of xenon in hypoxic-ischemic encephalopathy (HIE) and asphyxia neonatorum (2 arms), sponsored by Imperial College London. Primary endpoint: Primary neuroimaging endpoint. Started Mar 2010; status: completed.

02

Drugs

xenon
03

Conditions

hypoxic-ischemic encephalopathy (HIE)asphyxia neonatorum

Beyond the preview

Go deeper on 2009-014344-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014344-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call